Eulerpool Terminal
The edge that pays for itself.
Current BioXcel Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
14.89 USD
+1,646.25 %
Median
12.24 USD
+1,335.27 %
Max
39.90 USD
Min
1.01 USD
Last Price
0.85 USD
Buy
9
Hold
1
Sell
1
The average target price for BioXcel Therapeutics is 14.89 USD. (+1,646.25 % above the current price)
The median price target of BioXcel Therapeutics is 12.24 USD.
Stock analysts from many renowned investment banks are closely examining the BioXcel Therapeutics stock. They conclude their professional BioXcel Therapeutics stock analyses with a clear recommendation for the BioXcel Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 9 | 1 | 1 | 14.89 USD |
| 2026-01-01 | 9 | 1 | 1 | 16.12 USD |
| 2025-12-01 | 9 | 1 | 1 | 16.12 USD |
| 2025-12-01 | 9 | 1 | 1 | 16.12 USD |
| 2025-11-01 | 9 | 1 | 1 | 21.83 USD |
| 2025-11-01 | 9 | 1 | 1 | 18.87 USD |
BioXcel Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for BioXcel Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 1.00 M USD | -37.00 M USD | -3.03 USD |
| 2027e | 25.00 M USD | -38.00 M USD | -3.11 USD |
| 2028e | 63.00 M USD | -17.00 M USD | -1.39 USD |